针对最初无法切除的胃癌,基于免疫治疗的转换治疗的生存率和多组体分析
Song Li1, Qian Xu1, Wenbin Yu2
1Department of Medical Oncology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, China.
Frontiers in immunology
|January 29, 2026
概括
免疫检查点抑制剂 (ICI) 对不可切割的胃癌转化疗法有希望,改善生存率并使手术成为可能. 多omics分析确定了疗效和耐药性的生物标志物.
科学领域:
- 在瘤学瘤学.
- 胃肠病学 胃肠病学
- 免疫治疗是一种免疫疗法.
背景情况:
- 免疫检查点抑制剂 (ICI) 在可切除和晚期胃癌中有效.
- 它们在最初无法切除的胃癌中的作用尚不清楚.
研究的目的:
- 评估基于ICI的转化疗法在不可切割的胃癌中的疗效.
- 探索反应和抵抗的分子机制.
主要方法:
- 在接受ICI治疗的73名无法切除的胃癌患者的回顾性队列研究中.
- 主要终点:病理反应率 (pCR,MPR) 和R0切除.
- 二级终点:生存率 (OS,DFS,EFS),安全性,以及多组组分析.
主要成果:
- 82.2%的患者接受了彻底手术;中位数的EFS是手术后30.9个月.
- 病理完整反应 (pCR) 和主要病理反应 (MPR) 的比率分别为24.7%和37.0%.
- KMT2D突变与更好的结果相关,而细胞染色体P450表明了耐药性.
结论:
- 基于ICI的转化疗法为不可切除的胃癌提供了生存益处和可接受的安全性.
- 这一战略提供了现实世界的证据,多omics数据揭示了潜在的生物标志物.
更多相关视频
08:51Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts
Published on: September 20, 2024
2.1K
09:02Percutaneous Hepatic Perfusion PHP with Melphalan as a Treatment for Unresectable Metastases Confined to the Liver
Published on: July 31, 2016
12.4K
相关概念视频
Cancer Survival Analysis
756
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
756
Introduction To Survival Analysis
779
Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time...
The primary goal of survival analysis is to estimate survival time—the time...
779
Comparing the Survival Analysis of Two or More Groups
594
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
594
Truncation in Survival Analysis
616
Truncation in survival analysis refers to the exclusion of individuals or events from the dataset based on specific criteria related to the time of the event. This exclusion can happen in two primary forms: left truncation and right truncation.
Left truncation occurs when individuals who experienced the event of interest before a certain time are not included in the study. This is often due to a "delayed entry" into the study where only those who survive until a certain entry point are...
Left truncation occurs when individuals who experienced the event of interest before a certain time are not included in the study. This is often due to a "delayed entry" into the study where only those who survive until a certain entry point are...
616
Assumptions of Survival Analysis
421
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
421
Gene Conversion
10.6K
Other than maintaining genome stability via DNA repair, homologous recombination plays an important role in diversifying the genome. In fact, the recombination of sequences forms the molecular basis of genomic evolution. Random and non-random permutations of genomic sequences create a library of new amalgamated sequences. These newly formed genomes can determine the fitness and survival of cells. In bacteria, homologous and non-homologous types of recombination lead to the evolution of new...
10.6K
